Log In
BCIQ
Print this Print this
 

MEDI-5872

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionAnti-B7RP1 mAb
Molecular Target B7 related protein 1 (B7RP-1)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationLupus
Indication DetailsTreat systemic lupus erythematosus (SLE)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today